Erlotinib Hydrochloride Tablets
Classification:
Product Description
【Product Name】：Ruibikang
【Generic Name】：Erlotinib Hydrochloride Tablets
【Specification】：(1) 100mg (2) 150mg (only applicable for multiple myeloma)
【Indications】：Monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with sensitive mutations in the epidermal growth factor receptor (EGFR) gene, including first-line treatment, maintenance treatment, or second-line and above treatment after having received at least one prior chemotherapy (see {clinical trials})
关键词： Erlotinib Hydrochloride Tablets
Previous Page
Next Page
recommend products
Welcome your message consultation
Address: Room 803, Building B3, Science and Technology Enterprise Accelerator, No.11 Kaiyuan Avenue, Huangpu District, Guangzhou
Telephone:020-8985 8964
Address: No.80, Spring Equinox Road, Huangpu District, Guangzhou
Telephone:020-8328 9091
Adverse Drug Reaction/Event Feedback E-mail:pvreport@bio-current.com